undamentalytics Newsletter
Sign in

Rockwell Medical, Inc. key statistics and ratios

In fiscal 2025, Rockwell Medical, Inc. had return on equity of -15.3% and a net margin of -7.7%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Net margin−10.1%−4.5%−43.8%−108.4%−93.1%−39.4%−26.1%−37.2%−45.2%−50.7%−55.7%−49.7%−52.8%−25.7%−10.1%−0.5%−7.7%−7.3%
Return on equity−18.8%−9.0%−87.9%——−61.6%−22.0%−34.4%−60.4%−106.7%−143.4%−113.4%−178.0%—−47.7%−1.8%−15.3%−14.1%
Return on assets—−7.3%−62.2%−220.7%−182.8%−31.7%−15.5%−23.2%−36.5%−57.7%−70.5%−50.6%−51.7%−39.2%−17.1%−0.9%−9.1%−8.9%
R&D as % of revenue11.8%5.7%36.4%96.8%75.2%14.4%9.0%11.0%11.0%8.9%11.2%11.4%11.0%4.3%1.3%0.0%0.0%—
SG&A as % of revenue12.6%15.6%19.4%25.4%27.4%33.8%34.5%39.6%40.7%36.4%————————

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

6 of 7 checks passed · June 30, 2026
What it owns · $57m
Short-term assets $36mLonger-term assets $20m
What it owes, and who funded it · $57m
Short-term liabilities $11mLonger-term liabilities $10mShareholders' equity $35m
  • Short-term assets cover short-term liabilities $36m of assets due within a year against $11m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $36m short-term assets against $10m of longer-dated liabilities.
  • More cash than debt $11m of cash against $9m of debt.
  • Debt below 40% of shareholders' equity Debt is 26% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 520% to 26% over five years.
  • A year's operating cash flow covers at least 20% of debt $3m of operating cash flow against $9m of debt.
  • Operating profit covers interest at least five times over Operating income of −$5m against $1m of interest.

From Rockwell Medical, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

35 /100

Weak moat

How hard Rockwell Medical's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -21.3% of total assets over 7 years.

  • Pricing power 2 / 20

    Gross margin has been a median 8.3%, moving by 8.2 percentage points (standard deviation) across 10 years.

  • Durability 10 / 20

    Operating margin has been a median -40.1%; its worst year was -54.4%.

  • Discipline 20 / 20

    The diluted share count fell 97.7% over five years; stock-based pay has been a median 2.1% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (40 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: DERM vs RMTIAYTU vs RMTIAQST vs RMTI

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Rockwell Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Rockwell Medical, Inc.